Since the turn of the 20th century there has been increasing evidence that cancer patients who contract a viral infection can undergo periods of clinical remission.
However, researchers had struggled for decades to safely and effectively harness this power.
Now we enter a new dawn where viruses can be engineered to replicate selectively in tumours, destroy malignant cells and reprogram our immune system to respond to a broad range of solid tumours.
British Journal of Haematology, 2021, 192, 415
We use cookies to analyze website traffic and optimize your website experience and not for advertising. By accepting our use of cookies, your data will be aggregated with all other user data. We value transparency and a link to our privacy policy can be found on our Contact Us page.